112 related articles for article (PubMed ID: 34225727)
1. A computational multi-targeting approach for drug repositioning for psoriasis treatment.
Ibezim A; Onah E; Dim EN; Ntie-Kang F
BMC Complement Med Ther; 2021 Jul; 21(1):193. PubMed ID: 34225727
[TBL] [Abstract][Full Text] [Related]
2. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.
Arodola OA; Soliman ME
Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167
[TBL] [Abstract][Full Text] [Related]
3. Design and Construction of Aroyl-Hydrazone Derivatives: Synthesis, Crystal Structure, Molecular Docking and Their Biological Activities.
Kumari P; Ansari SN; Kumar R; Saini AK; Mobin SM
Chem Biodivers; 2019 Nov; 16(11):e1900315. PubMed ID: 31532059
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
[TBL] [Abstract][Full Text] [Related]
5. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S
Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467
[TBL] [Abstract][Full Text] [Related]
6. [Exploration of active components and mechanism of Scutellariae Radix-Phellodendri Chinensis Cortex drug pair in treatment of psoriasis based on network pharmacology and molecular docking].
Ma BZ; Li D; Wang HY; Tang YH; Bai D; He J; Liu X
Zhongguo Zhong Yao Za Zhi; 2021 Oct; 46(20):5330-5340. PubMed ID: 34738437
[TBL] [Abstract][Full Text] [Related]
7. Silybin B and Cianidanol Inhibit M
Srivastava R; Tripathi S; Unni S; Hussain A; Haque S; Dasgupta N; Singh V; Mishra BN
Curr Pharm Des; 2021; 27(32):3476-3489. PubMed ID: 33302853
[TBL] [Abstract][Full Text] [Related]
8. Compounds Identified from Marine Mangrove Plant
Aljahdali MO; Molla MHR; Ahammad F
Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33925208
[TBL] [Abstract][Full Text] [Related]
9. Drug Target Identification and Drug Repurposing in Psoriasis through Systems Biology Approach, DNN-Based DTI Model and Genome-Wide Microarray Data.
Zhan YP; Chen BS
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373186
[TBL] [Abstract][Full Text] [Related]
10. Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2-P3 α-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach.
Achilonu I; Iwuchukwu EA; Achilonu OJ; Fernandes MA; Sayed Y
J Mol Graph Model; 2020 Dec; 101():107730. PubMed ID: 32920239
[TBL] [Abstract][Full Text] [Related]
11. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data.
Chakraborti S; Bheemireddy S; Srinivasan N
Mol Omics; 2020 Oct; 16(5):474-491. PubMed ID: 32696772
[TBL] [Abstract][Full Text] [Related]
12. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
[TBL] [Abstract][Full Text] [Related]
13. Computational Approaches Towards Kinases as Attractive Targets for Anticancer Drug Discovery and Development.
Hameed R; Khan A; Khan S; Perveen S
Anticancer Agents Med Chem; 2019; 19(5):592-598. PubMed ID: 30306880
[TBL] [Abstract][Full Text] [Related]
14. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
15. New JAK inhibitors for the treatment of psoriasis and psoriatic arthritis.
D'Urso DF; Chiricozzi A; Pirro F; Calabrese L; Caldarola G; Fossati B; De Simone C; Peris K
G Ital Dermatol Venereol; 2020 Aug; 155(4):411-420. PubMed ID: 32545945
[TBL] [Abstract][Full Text] [Related]
16. Herbal Lead as Ideal Bioactive Compounds Against Probable Drug Targets of Ebola Virus in Comparison with Known Chemical Analogue: A Computational Drug Discovery Perspective.
Setlur AS; Naik SY; Skariyachan S
Interdiscip Sci; 2017 Jun; 9(2):254-277. PubMed ID: 26857866
[TBL] [Abstract][Full Text] [Related]
17. Deciphering metabonomics biomarkers-targets interactions for psoriasis vulgaris by network pharmacology.
Gu J; Li L; Wang D; Zhu W; Han L; Zhao R; Xu X; Lu C
Ann Med; 2018 Jun; 50(4):323-332. PubMed ID: 29537306
[TBL] [Abstract][Full Text] [Related]
18. Dual inhibitors of SARS-CoV-2 proteases: pharmacophore and molecular dynamics based drug repositioning and phytochemical leads.
Mitra K; Ghanta P; Acharya S; Chakrapani G; Ramaiah B; Doble M
J Biomol Struct Dyn; 2021 Oct; 39(16):6324-6337. PubMed ID: 32698693
[TBL] [Abstract][Full Text] [Related]
19. In Silico Chemogenomics Drug Repositioning Strategies for Neglected Tropical Diseases.
Andrade CH; Neves BJ; Melo-Filho CC; Rodrigues J; Silva DC; Braga RC; Cravo PVL
Curr Med Chem; 2019; 26(23):4355-4379. PubMed ID: 29521204
[TBL] [Abstract][Full Text] [Related]
20. Drug Re-positioning Studies for Novel HIV-1 Inhibitors Using Binary QSAR Models and Multi-target-driven In Silico Studies.
Dogan B; Durdagi S
Mol Inform; 2021 Feb; 40(2):e2000012. PubMed ID: 33405326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
